eCORE
- Cancer
- Global Health
Team
Group Leader
Matilde E. LLeonart and David Virós
Principal Investigator (PI)
Matilde E. LLeonart
Researchers
Yoelsis García-Mayea, Almudena Sánchez García, Laura Grau de Diego, Sílvia Naches Solsona, Juan Fernando Fuentes, Pablo Vergés, David Virós, Matilde E. LLeonart
PhD Students
Marina Bataller Fernández, Gaomiyang Liu, Yang Hong
Selected Publications
Paciucci R, Carnero A, LLeonart ME.
Editorial: Reciprocal crosstalk between the tumor microenvironment and cancer stem cells.
Front Immunol. 2024 Nov 5;15:1505225.
DOI: 10.3389/fimmu.2024.1505225
IF: 5.7
Albert Pujol , Xavier León , Anna Holgado , Cristina Valero , Katarzyna Kolanczak, Miquel Quer, David Virós
External validation of the GETTEC algorithm for elective neck dissection in patients candidates for salvage total laryngectomy
Oral Oncol
DOI: 10.1016/j.oraloncology.2024.106686
IF: 4
Llansana, A; Viros Porcuna, D; Vasquez, R; Parellada,
A; Valero, C; Holgado, A; Leon, X
PATH classification: a proposal for patients with HNSCC treated with salvage surgery.
European Archives of Oto-Rhino-Laryngology. Springer. 282-2, pp.971-979.
DOI: 10.1007/s00405-024-08961-x
IF: 1.9
Viros Porcuna, D (AC); Pollan Guisasola, CM; Viña Soria, C;
Verges Fort, P; Palau Viarnes, M; Juesas Iglesias, L; De Virgilio, A
Transoral Robotic Parapharyngeal Space Dissection
Head & Neck. Wiley. 46-10, pp.2657-266.
DOI: 10.1002/hed.27902
IF: 2.4
De Virgilio, A; Viros Porcuna, D; Sampieri, C; Constantino, A.
Is the robot an instrument or an indication for transoral surgery?
2024. Oral Oncology. Elsevier. 153, pp.106716.
DOI: 10.1016/j.oraloncology.2024.106716
IF: 4
Selected Projects
“New therapeutic approaches in head and neck cancer”
Principal Investigator: Matilde E. LLeonart
Agency: Ministerio de Salud Carlos III
Funding: 183,920 €
Period: 2021-2025
Novel therapeutic approaches against COVID-19
Principal Investigator: Matilde E. LLeonart
Agency: La Marató TV3
Funding: 161,875 VHIR (297,000 € whole consortium)
Period: 2022-2024 (3y)
New compounds targeting head and neck cancer as Trojan horses against chemoresistant cells
Principal Investigator: Matilde E. LLeonart
Agency: Agaur
Funding: 20,000 €
Period: 2024 (6m)
Patents
“COMPOUNDS FOR USE IN THE TREATMENT OF CANCERS THAT OVEREXPRESS TSPAN1”
Priority Number: EP23383269
Priority Date: 10/12/2024
Applicants: 60% VHIR, 20% URiV, 20% IQAC-CSIC
Selected Dissemination Activities
Visites escolars en el Dia de les nenes, les dones i la ciència
Place: VHIR
Date: 02/11/2024
Brief: Visit of children from High School to visit our laboratory
MORE INFO
EscoLab
Place: VHIR
Date: 04/10/2024
Brief: VIsit of teenagers from High School to our laboratory
MORE INFO
Visit associatted to the Marato TV3 Project
Place: VHIR
Date: 06/04/2024
Brief: Disseminnation video promoted by La Marató TV3 Foundation
MORE INFO
International Day of Head and Neck cancer
Place: HUVH
Date: 01/01/1970
Brief: Organization of a stand at the entrence of the HUVH with disseminnation activites for patients and families
MORE INFO